
Hit by rupee appreciation, domestic pharma players including Ranbaxy Laboratories, Biocon, and Dabur Pharma have started taking measures like hedging,…
Hit by rupee appreciation, domestic pharma players including Ranbaxy Laboratories, Biocon, and Dabur Pharma have started taking measures like hedging,…
After introducing the emergency contraceptive i-pill, Mumbai-based pharma major Cipla is now planning to launch the new generation oral contraceptive…
Even as pharma major Pfizer recently withdrew its inhaled product for diabetes, India with huge diabetes population seems to attract…
SAIL is likely to miss its deadline of achieving saleable steel production of 25 MT by 2010, as the steel…
The morning-after pill may seem the easiest way to avoid unwanted pregnancies but the recently launched ?i-pill? by pharma major…
In order to tap $3 billion diabetes market in the European Union, Mumbai-based pharma major Wockhardt Ltd is in talks…
In order to tap the $35 billion oncology market globally, Indian drug makers including Ranbaxy, Dr Reddy?s, Biocon, and Dabur…
Given the land acquisition problems faced by various steel companies including ArcelorMittal and Posco to set up proposed steel plants,…
Kicking off the restructuring process of Orissa Mines Corporation (OMC), which has a reserve of less than 1 billion tonne…
State-owned SAIL is all set to sign Rs 969-crore MoU with Indian Railways, NMDC and Chhattisgarh government to lay 235…
Delhi-based vaccine manufacturer Panacea Biotec is eyeing the $1 billion market in gastrointestinal segment both in the US and Europe…
Ahemadabad-based Torrent Pharma is looking at increasing its presence in the global market and is understood to be in talks…
Trying their best to avoid fixation of iron-ore royalty on ad-valorem basis, the Federation of Indian Mineral Industries has proposed…
The Planning Commission, in a note to the group of ministers on the national pharma policy, has said any move…
With consumers becoming more health conscious and prefering healthy food, PepsiCo has fine-tuned its strategy to increase its share in…
Unable to make pharmaceutical companies reduce the prices of essential drugs, the government is now planning to find out if…
Brazil?s loss is India?s gain. Steel makers in China have turned to India following an increase of about 100% in…
With a view to bridge the gap between demand and supply of trained manpower for the domestic pharma industry, the…